Canadian Drug Company Awarded Rwandan Contract To Provide Combination Antiretroviral

Rwanda recently accepted a bid from the Toronto-based generic drug company Apotex to supply its fixed-dose combination antiretroviral drug Apo-triAvir to the country, the Toronto Star reports (Toronto Star, 5/9). According to the CP/Google.

http://www.medicalnewstoday.com/articles/107251.php